As expected, patients in cluster A had higher immune cytolytic activity or CYT scores compared to those in cluster B. Disease stage, tumor grade, age at diagnosis, PR status, and ERBB2 (HER2) overexpression were not significantly different between the two cell clusters. Here, ERBB2 is linked to neoplasm.